A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...
An algorithm paired with a continuous glucose monitor can help people living with type 2 diabetes better manage their condition by recommending insulin-dose adjustments. This is the claim of ...
A University of Virginia Center for Diabetes Technology-developed algorithm, paired with a continuous glucose monitor, can help users better manage their Type 2 diabetes by recommending insulin-dose ...
PharmaSens AG, a Swiss developer of next-generation insulin patch pump systems, announced that the Journal of Diabetes Science and Technology (JDST) has published data from the first clinical study ...
A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...
Irvine-based Beta Bionics, which recently went public, saw two-year revenue increase more than eight-fold to $103.2 million.
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2026 on Wednesday, June 3, 2026. A ...
Discover how MiniMed's full-stack diabetes technology and global reach post-IPO could transform a rapidly growing $18B ...
A newly discovered molecule could reshape the future of weight loss treatments by mimicking the powerful appetite-suppressing ...
IRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Beta Bionics today announced the launch of Bionic Insights™ , an innovative new feature within its Bionic Reports, designed to help healthcare ...
MiniMed Group Inc. is back as a locally based publicly traded company, having come full circle after 30 years. The Northridge ...
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2026 financial results ...